American Heart Association (AHA)
National Center
7272 Greenville Avenue
Dallas
Texas
75231
United States
Tel: 800-242-8721
Website: http://www.americanheart.org/
608 articles about American Heart Association (AHA)
-
Ionis' pioneering antisense technology to be featured in multiple presentations at American Heart Association (AHA) Scientific Sessions 2020
11/12/2020
Ionis' novel antisense medicine targeting PCSK9 demonstrates best-in-class potential for the treatment of patients with high cholesterol at risk for cardiovascular disease
-
Pioneering coach, Sylvester Croom named Heart of a Champion Award recipient
10/29/2020
The American Heart Association's 2021 Paul "Bear" Bryant Heart of a Champion Award honors a college football coach for outstanding accomplishments both on and off the field
-
33 Organizations Representing Millions of Patients Urge Policymakers to Adopt "Patient-First" Policy Agenda
10/13/2020
A coalition of 33 organizations representing millions of people with pre-existing conditions launched an unprecedented effort by releasing their top priorities for the next Administration.
-
The American Heart Association and KLA Foundation create $1.5 million Social Equity Fund for COVID-19 relief in California and Michigan
10/12/2020
Fund seeks applications from local non-profits in affected communities in Silicon Valley, South Bay and Detroit metro area
-
Eight Genesis HealthCare Facilities Receive New American Heart Association Post-Acute Care Heart Failure Center Certification
7/23/2020
As part of an effort to reduce avoidable hospital readmissions along with gaps in care coordination both within and across settings, and to improve outcomes for patients, the American Heart Association has awarded the first Post-Acute Care Heart Failure Center Certification to eight Genesis HealthCare skilled nursing facilities.
-
Ride Health CEO Imran Cronk to Present at South by Southwest Alongside Leaders from American Heart Association and Ascension
3/3/2020
Company also exhibiting cloud-based transportation coordination platform at RISE Medicare Advantage Summit and AMGA Annual Conference
-
National Wear Red Day is tomorrow, Feb. 7, 2020
2/6/2020
The American Heart Association's Go Red for Women® movement invites you to wear red with heart-health advocates nationwide demanding better care, greater inclusion of women in research
-
CVS Health to Offer No-Cost Heart Health Screenings in Support of Women's Heart Health
1/28/2020
Screenings available on select Thursdays in February at MinuteClinic locations nationwide
-
The American Heart Association ("AHA") Recognizes Mezzion's FUEL Trial as the Biggest Victory in Congenital Heart Disease ("CHD") Advancements for 2019
1/9/2020
The National Heart, Lung, and Blood Institute also Recognizes the FUEL Trial as an Advancement in CHD for 2019
-
Portola Pharmaceuticals to Support New American Heart Association Initiative to Address Hemorrhagic Stroke
12/17/2019
American Heart Association Quality Improvement Project Promotes Patient Education and Physician Best Practices for Hemorrhagic Stroke
-
Patrick Magoon To Receive American Heart Association's Prestigious Heart Of Gold Award At 2020 Chicago Heart Ball
12/4/2019
Patrick Magoon, outgoing president and chief executive officer at Ann & Robert H. Lurie Children's Hospital of Chicago, will receive the American Heart Association's prestigious Heart of Gold Award at the Chicago Heart Ball on Saturday, April 4.
-
Perspecta Raises More Than $320,000 for the American Heart Association; Sets New Record
12/3/2019
This fundraising achievement makes Perspecta the largest, single-year fundraising company in history for the Greater Washington Heart Walk, two years in row, breaking its previous record of $310,000.
-
Bayer Announces National Sponsorship of the American Heart Association and the American Diabetes Association's Know Diabetes by Heart initiative
11/20/2019
Bayer announced it has joined Know Diabetes by Heart™, a joint initiative of the American Heart Association and the American Diabetes Association, as a national sponsor.
-
Liminal Presents New Preclinical Data on PBI-4050 and its Effect on Angio-Proliferative Pulmonary Arterial Hypertension
11/19/2019
Liminal BioSciences Inc. announced the presentation of two scientific posters with new preclinical data for PBI-4050 and the treatment of pulmonary arterial hypertension at the American Heart Association 2019 conference taking place on November 16-18, 2019 in Philadelphia, PA..
-
Endotronix Announces Positive Data from the SIRONA First-in-Human Trial for the Cordella™ PA Pressure Sensor System
11/18/2019
Data presented at the 2019 American Heart Association Scientific Sessions
-
Interim analysis from EMPRISE real-world study shows Jardiance® decreased risk of hospitalization for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists
11/17/2019
This analysis on effectiveness also shows Jardiance® (empagliflozin) was associated with a similar risk of non-fatal atherosclerotic cardiovascular events compared with DPP-4 inhibitors or GLP-1 receptor agonists
-
ISCHEMIA-CKD Trial: Advanced Chronic Kidney Disease Patients Treated with Invasive Heart Procedures Show No Reduction in Rate of Cardiac Events
11/16/2019
Heart disease is the leading cause of death for the roughly 500 million people worldwide with chronic kidney disease Yet such patients have been excluded from most of the major, relevant cardiovascular clinical trials that are meant to guide treatment approaches for them.
-
Kiniksa Presents Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
11/16/2019
Rapid resolution of both reported pain and inflammation as well as improvement in quality of life scores
-
Mezzion Pharma announces Top Line Data from FUEL will be presented at the American Heart Association (AHA), Late Breaking Scientific Sessions, in Philadelphia, PA, November 17, 2019
11/4/2019
Mezzion Pharma Co. Ltd. announces that on Sunday, November 17, 2019, at 10:45 am EST, Dr. David Goldberg, Children's Hospital of Philadelphia, will present the results of Mezzion's landmark FUEL Phase 3 Clinical Trial.
-
MyoKardia Announces Abstracts Selected for Presentation at the American Heart Association Scientific Sessions 2019Company to Host Conference Call and Webcast on November 11, 2019 at 8:30 a.m. ET (5:30 a.m. PT)
11/4/2019
The abstracts include new data from the ongoing PIONEER open-label extension (PIONEER-OLE) study of mavacamten, preclinical studies of mavacamten and MYK-491, and hypertrophic cardiomyopathy (HCM) population insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).